← Back to headlines
Amgen's Q2 Sales for Enbrel and Otezla Rebound
Amgen reported a quarter-over-quarter rebound in Q2 sales for its drugs Enbrel and Otezla, despite facing ongoing year-over-year headwinds.
5 Aug, 07:02 — 5 Aug, 07:02
Sources
Showing 1 of 1 sources
